Login / Signup

Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients.

Lauren J AndrewsJamie BenkenEnrico BenedettiHokuto NishiokaDana PierceKaitlyn DaltonJustin HanBona ShinScott T Benken
Published in: Clinical transplantation (2022)
Based on the observations of this pilot study, ATII is a safe and effective vasopressor option for renal transplant recipients requiring perioperative hypotension reversal.
Keyphrases
  • angiotensin ii
  • cardiac surgery
  • angiotensin converting enzyme
  • patients undergoing
  • vascular smooth muscle cells
  • acute kidney injury